评估肝硬化患者的营养状况
Barbara Janota1, Aneta Krupowicz2, Kinga Noras3
1Department of Basic Medical Sciences, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, Bytom 41-902, Poland.
World journal of hepatology
|August 7, 2023
概括
营养不良随着肝纤维化进展而恶化,影响营养状况参数. 查尔德-普格评分有效地表明了晚期肝病患者营养不良的严重程度.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 营养科学 营养科学
- 临床医学 临床医学
背景情况:
- 肝病患者,特别是肝硬化患者中,营养不良很常见.
- 早期识别和营养干预对于管理晚期慢性肝病中营养不良至关重要.
研究的目的:
- 评估不同程度的晚期肝纤维化患者的营养状况.
- 用多个营养参数进行全面评估.
主要方法:
- 118名肝硬化患者被分为三个Child-Pugh分数组.
- 用各种评估方法评估营养状况.
- 统计分析包括单向ANOVA和相关性分析,以确定疾病阶段的影响.
主要成果:
- 营养指标如体重,BMI和手臂周长通常随着肝病严重程度的增加而下降 (Child-Pugh评分).
- 查尔德-普格分类和主观的全球评估,手臂周长,体重,白蛋白和各种身体成分指数之间观察到强烈的相关性.
- 营养不良指标显示,随着肝纤维化进展,病情明显恶化.
结论:
- 晚期肝纤维化严重影响营养状况.
- 营养不良的程度与肝纤维化的进展相关.
- 查尔德-普格评分作为这些患者营养状况的可靠指标.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
96
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
96
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Ultrasound II: Endoscopic Ultrasound and FibroScan
139
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
139
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Diseases of the Liver and Gallbladder
631
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
631
Liver Physiology
635
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
635


